These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4738887)

  • 1. [Hageman factor (Factor XII) in retinal vein obstruction].
    Kimura S; Arai M
    Nippon Ganka Gakkai Zasshi; 1973 Jun; 77(6):587-93. PubMed ID: 4738887
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug action--study of plasma protein variations in hyperthrombotic diseases using gel filtration chromatography on agarose.
    Morelli AC; Pollini H; Del Pino MC
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):259-68. PubMed ID: 5357865
    [No Abstract]   [Full Text] [Related]  

  • 3. Should factor XII assays be included in thrombophilia screening?
    Winter M; Gallimore M; Jones DW
    Lancet; 1995 Jul; 346(8966):52. PubMed ID: 7603161
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between kallikrein release and factor XII in normal persons and carriers of the Hageman trait.
    Torres M; Ercoreca L; Lucia JF; Giralt M; Raichs A
    Thromb Haemost; 1979 Dec; 42(4):1286-8. PubMed ID: 261563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hageman factor (factor XII) in health and diseases.
    Saito H
    Nihon Ketsueki Gakkai Zasshi; 1981 Dec; 44(7):1460-5. PubMed ID: 7342648
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of Hageman factor and initiation of hepatic vein thrombosis in the hyperlipemic rat.
    Latour JG; Léger C; Renaud S
    Am J Pathol; 1974 Aug; 76(2):179-94. PubMed ID: 4843381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of factor XII in antiphospholipid antibody-positive patients with thrombotic events in the rheumatology clinic.
    Takeishi M; Mimori A; Nakajima K; Mimura T; Suzuki T
    Clin Rheumatol; 2003 Feb; 22(1):40-4. PubMed ID: 12605317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factor XII (Hageman factor)].
    Saito H
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():87-9. PubMed ID: 8753188
    [No Abstract]   [Full Text] [Related]  

  • 9. [Factor XII (Hageman factor)].
    Saito H
    Nihon Rinsho; 1999 Sep; 57 Suppl():622-4. PubMed ID: 10543195
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasma factor XII (Hageman factor) in disease states (author's transl)].
    Ichinose A; Maruyama I; Imaguma M; Sonoda T; Igata A
    Rinsho Ketsueki; 1981 Aug; 22(8):1232-6. PubMed ID: 7328776
    [No Abstract]   [Full Text] [Related]  

  • 11. Hageman factor (factor XII) in cerebrovascular diseases.
    Shinmyozu K; Ichinose A; Maruyama I; Igata A
    Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):212-23. PubMed ID: 4003007
    [No Abstract]   [Full Text] [Related]  

  • 12. [Factor XII (Hageman factor)].
    Saito H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():657-9. PubMed ID: 15658416
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chromatographic method of analyzing Hageman factor (blood coagulation factor XII) in human serum].
    Krizhevskaia IuV; Dotsenko VL; Iarovaia GA
    Vopr Med Khim; 1982; 28(2):128-32. PubMed ID: 7080474
    [No Abstract]   [Full Text] [Related]  

  • 14. Factor XII (Hageman) levels in women with recurrent pregnancy loss.
    Ozgu-Erdinc AS; Togrul C; Aktulay A; Buyukkagnici U; Yapar Eyi EG; Erkaya S
    J Pregnancy; 2014; 2014():459192. PubMed ID: 25436153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Hageman factor and its active forms. Separation, methods of determination and its characteristics].
    Simonianová E; Rybák M
    Cesk Farm; 1986 Apr; 35(3):134-7. PubMed ID: 3719709
    [No Abstract]   [Full Text] [Related]  

  • 16. [Promotion mechanism of vascular permeability by Hageman factor].
    Yamamoto T
    Rinsho Byori; 1982 Jun; Suppl 50():114-26. PubMed ID: 7131802
    [No Abstract]   [Full Text] [Related]  

  • 17. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].
    Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M
    Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hageman factor deposition in membranous glomerulopathy.
    Berger J; Yaneva H
    Transplant Proc; 1982 Sep; 14(3):472-3. PubMed ID: 6758235
    [No Abstract]   [Full Text] [Related]  

  • 19. Hageman factor activity in liquoid-induced consumption coagulopathy. Failure to prevent the drop in Hageman factor activity by anticoagulation with a coumarin derivative.
    Müller-Berghaus G; Lasch HG
    Thromb Diath Haemorrh; 1971 Aug; 26(1):58-70. PubMed ID: 5112377
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between factor XII, von Willebrand factor and postoperative deep vein thrombosis.
    Nilsson T; Mellbring G; Hedner U
    Acta Chir Scand; 1986 May; 152():347-9. PubMed ID: 3090810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.